AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw its Most Favored Nation model interim final rule and “replace it with a serious effort at drug pricing reform.” 

Effective Jan. 1 for most hospitals, the interim final rule cuts payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.  

“Instead of directly tackling the skyrocketing cost of drugs, this rule puts hospitals in the untenable position of having to divert resources from other patient care simply to buy the drug therapies they need for their patients,” AHA wrote. “And instead of enacting thoughtful policies that attempt to lower drug prices, this rule puts patients at risk. Indeed, CMS itself states that it expects beneficiaries’ access to drugs to be impeded, requiring them to accept less-effective treatments or forgo or postpone necessary care. In addition, the agency makes the breathtaking estimate that, within three years, nearly one in five Medicare Part B enrollees may have no access to drugs subject to the MFN rule.”

The AHA last month filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the rule from cutting payments for certain Medicare Part B drugs and biologicals. 

Related News Articles

Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…
Headline
The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and…
Headline
A report by the Department of Health and Human Services Office of the Inspector General found that many Medicare Advantage and Medicaid managed care plans…
Headline
Medicare open enrollment for 2026 began Oct. 15 and runs through Dec. 7. During the annual enrollment period, Medicare-eligible individuals can check their…
Headline
The AHA Oct. 3 responded to the Medicare Payment Advisory Commission’s recent analysis on the financial impacts of Medicare Advantage enrollment growth on…